GlobeNewswire

New review prioritizes maternal mental health during pregnancy
12/08/2026
Children’s National-led study highlights the benefits of treating major depression during pregnancy and the importance of balanced decision-making around SSRI use Washington, DC, Aug. 12, 2026 (GLOBE NEWSWIRE) -- [...]
Robotic Technology at Medicana: CyberKnife Tracks Tumors in Real Time and Adjusts Radiation as Patients Breathe
12/08/2026
Medicana Health Group radiation oncologist Prof. Dr. Kaan Oysul says real-time motion tracking helps keep radiation focused on moving tumors while limiting exposure to nearby critical organs Photo: Prof. Dr. Kaan Toysul [...]
Regenix Labs Announces Educational Guide on Cortisol, Stress Management, and Healthy Adrenal Function
12/08/2026
New educational guide explores cortisol, stress management, and nutritional ingredients that support overall wellness and healthy adrenal function. Regenix Labs logo. NEWARK, Del., Aug. 12, 2026 (GLOBE NEWSWIRE) -- [...]
Applied Biologics Launches National Health System Partnership Initiative
12/08/2026
Company expands strategic engagement with health systems, integrated delivery networks, and group purchasing organizations to support physicians and patients nationwide SCOTTSDALE, Ariz., Aug. 12, 2026 (GLOBE NEWSWIRE [...]
Tris Pharma Expands Support for People Living with ADHD Through New Partnerships with Calm Health and ADHD Central
12/08/2026
Initiatives Provide New DYANAVEL® XR Patients With Digital Wellness Resources and Practical Organization Tools Designed to Support ADHD Care Beyond Medication MONMOUTH JUNCTION, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- [...]
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
12/08/2026
Dyadic to host earnings call on August 12 at 5:00 pm ET JUPITER, Fla., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied [...]
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
12/08/2026
Contrasting Science with Revolution Medicines and Erasca MELBOURNE, Australia, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused [...]
Aprea Therapeutics Announces Second Quarter 2026 Financial Results
12/08/2026
Enrollment in the ongoing Phase 1 dose escalation ACESOT-1051 trial of oral WEE1 inhibitor APR-1051 is accelerating as dose escalation advances Aprea plans to advance APR-1051 in uterine serous carcinoma (USC), and [...]
Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
12/08/2026
Agreement combines Austrianova’s Cell-in-a-Box® technology with San Raffaele Hospital’s stem cell-derived beta cell expertise through a research collaboration with Avaí Bio and Austrianova’s JV Company, Insulinova, [...]
SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination
12/08/2026
TEL AVIV, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
12/08/2026
Final histology and laboratory analyses support the study’s safety and performance objectives THE WOODLANDS, TX, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a [...]
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray
12/08/2026
Commercial launch supported by a dedicated national sales force, payer and institutional access, and multi-channel marketing campaign supporting adoption of REZENOPY ™ Targeting continued commercial execution through [...]
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
12/08/2026
Completed enrollment of MIST global Phase 2b trial of AP01 with 398 patients; topline data expected in the second half of 2027 Two abstracts accepted for presentation at the European Respiratory Society (ERS) Congress, [...]
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
12/08/2026
Completed pre-IND meeting with the FDA for CNTY-813, an iPSC-derived islet replacement therapy with functional cure potential in type 1 diabetes (T1D); IND submission on track for 4Q 2026 CNTY-813 preclinical data from [...]
Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026
12/08/2026
HOUSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule [...]
Marie-Hélène Laramée, présidente-directrice générale de la Fondation du CUSM, nommée au conseil d’administration de l’Association canadienne pour l’équité en santé des femmes
12/08/2026
La nomination de Marie-Hélène Laramée renforce la voix du Québec au sein du mouvement national. Son objectif : combler les lacunes en matière de recherche, de soins et de leadership en santé des femmes MONTREAL, 12 août [...]
MUHC Foundation President and CEO Marie-Hélène Laramée appointed to Women’s Health Collective Canada Board of Directors
12/08/2026
Laramée’s appointment strengthens Quebec’s voice in the national movement to close gaps in women’s health research, care, and leadership MONTREAL, Aug. 12, 2026 (GLOBE NEWSWIRE) -- The McGill University Health Centre ( [...]
Solana Company to Release Second Quarter 2026 Operating Results on August 14, 2026
12/08/2026
PHILADELPHIA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed digital asset treasury, infrastructure, and services company providing institutional access to [...]
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
12/08/2026
Milestone strengthens manufacturing flexibility and supports pivotal study readiness BURLINGTON, Mass, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum